Cleaved caspase 3 positivity was significantly increased with carboplatin, a chemotherapy drug used in the first line treatment for ovarian cancer compared with the PBS control (Figure 3a–e, P = 0.0098, Wilcoxon paired test). This evidence concerns the gene CASP3 and ovarian carcinoma.